- Conditions: Adenocarcinoma, Scirrhous,; Linitis Plastica; Stomach Neoplasms,; Stomach Diseases,; Neoplasms by Site; Neoplasms
Intervention: Drug: TKI258
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Condition: Endometrial Cancer
Intervention: Device: MIrena(LNG-IUS), oral MPA
Sponsors: Korean Gynecologic Oncology Group; Korean Gynecologic Oncology Group
Recruiting - verified May 2012 - Condition: Postoperative Ileus
Intervention: Other: Chewing gum
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified April 2012 - Conditions: Hysterectomy; Genital Diseases, Female; Pain
Intervention: Behavioral: Follow-up strategy
Sponsors: University Hospital, Linkoeping; University Hospital, Linkoeping
Recruiting - verified February 2012 - Condition: Postoperative Complications
Interventions: Drug: Placebo-saline; Drug: Dexamethasone 4 mg; Drug: Dexamethasone 8 mg
Sponsors: NorthShore University HealthSystem Research Institute; NorthShore University HealthSystem Research Institute
Recruiting - verified March 2012 - Conditions: Urinary Bladder, Overactive; Pelvic Organ Prolapse
Intervention: Other: Pre- and postoperative evaluations
Sponsors: Radboud University; Radboud University; Astellas Pharma Inc; Continentie Stichting Nederland (Continence Foundation The Netherlands)
Recruiting - verified January 2012 - Conditions: Healthy Adults; Gynecological Disease
Interventions: Drug: Sevoflurane; Drug: Propofol
Sponsors: Tampere University Hospital; Tampere University Hospital
Recruiting - verified September 2011 - Conditions: Pelvic Organ Prolapse; Gynecologic Cancers; Uterine Leiomyomata; Adenomyosis; Endometrial Hyperplasia; Other Abnormal Uterine and Vaginal Bleeding; Pelvic Mass; Pelvic Pain
Intervention:
Sponsors: University of South Florida; University of South Florida
Recruiting - verified October 2011 - Condition: Sexual Dysfunction, Physiological
Interventions: Device: Vaginal Renewal Program; Device: Vaginal Dilator
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified September 2011 - Condition: Urinary Tract Infection
Intervention: Drug: Nitrofurantoin
Sponsors: Duke University; Duke University
Recruiting - verified October 2011 - Condition: Vaginitis
Interventions: Drug: Palmitoylethanolamide vaginal cream; Drug: Placebo vaginal cream
Sponsors: Università degli Studi dell'Insubria; Università degli Studi dell'Insubria
Not yet recruiting - verified July 2011 - Conditions: Solid Tumors and Advanced Endometrial Cancer; Endometrial Cancer; Second-line Treatment; VEGF
Intervention: Drug: TKI258
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified December 2011 - Conditions: Cervical Cancer; Uterine Cancer; Vaginal Cancer; Carcinoma of the Vulva
Intervention: Procedure: Image-guided brachytherapy
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute
Recruiting - verified February 2012 - Conditions: Endometrial Cancer; Cervical Cancer
Intervention: Drug: Tachosil fibrin patch
Sponsors: Ruhr University of Bochum; Ruhr University of Bochum
Recruiting - verified November 2011 - Conditions: Breast Cancer; Gastrointestinal Cancer; Genitourinary Cancer; Sarcoma; Gynecologic Cancer
Interventions: Drug: Doxorubicin; Drug: Sildenafil
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University
Recruiting - verified April 2012 - Conditions: Uterine Cancer; Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Cervical Cancer; Vulvar Cancer
Intervention: Other: Survey
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified June 2011 - Conditions: Shoulder Pain; Nausea
Interventions: Procedure: Pulmonary recruitment maneuver; Procedure: Intraperitoneal normal saline infusion; Procedure: combined group; Procedure: Control group
Sponsors: Taipei Veterans General Hospital,Taiwan; Taipei Veterans General Hospital,Taiwan; National Yang Ming University
Recruiting - verified July 2011 - Condition: Surgical Procedure, Unspecified
Intervention: Behavioral: Computerized decision aid with 1 type of value clarification
Sponsors: University of California, San Francisco; University of California, San Francisco; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Hormone Receptor-Positive Breast; Gynecologic; Desmoid; Hormone Receptor-Positive Neoplasms
Interventions: Drug: z-Endoxifen; Drug: [(18)F] Fluoroestradiol
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified September 2011 - Condition: Endometrial Hyperplasia
Intervention: Device: Mirena (LNG-IUS)
Sponsors: Korean Gynecologic Oncology Group; Korean Gynecologic Oncology Group
Recruiting - verified May 2012 - Condition: Endometrial Cancer
Intervention: Drug: Metformin
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; American Cancer Society
Recruiting - verified May 2012 - Condition: Ovarian Cysts
Interventions: Drug: Ropivacaine nebulization; Drug: Ropivacaine instillation
Sponsors: San Gerardo Hospital; San Gerardo Hospital; Ospedali Riuniti di Bergamo
Recruiting - verified September 2011 - Conditions: Breast Cancer; Gynecologic Cancer
Intervention:
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified December 2011 - Conditions: Ovarian Carcinoma; Fallopian Tube Cancer; Peritoneal Cancer; Breast Carcinoma
Interventions: Drug: MLN8237 + Paclitaxel; Drug: MLN8237+Paclitaxel vs. Paclitaxel alone
Sponsors: Millennium Pharmaceuticals, Inc.; Millennium Pharmaceuticals, Inc.
Recruiting - verified December 2011 - Condition: Gynecologic Cancer
Intervention: Behavioral: Surveys
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified April 2012 - Conditions: Gastrointestinal Neoplasms; Gynecologic Cancers; Gynecologic Cancers Cervical Cancer; Gastric (Stomach) Cancer; Gastro-Esophageal(GE) Junction Cancer; Gastrointenstinal Stromal Tumor (GIST); Colon/Rectal Cancer; Colon/Rectal Cancer Colon Cancer; Colon/Rectal Cancer Rectal Cancer; Colon/Rectal Cancer Anal Cancer; Anal Cancer; Hepatobiliary Cancers; Hepatobiliary Cancers Liver; Pancreatic Cancer
Interventions: Procedure: Blood Draw; Procedure: Frozen Tumor Specimens
Sponsors: Stanford University; Stanford University; Caring for Carcinoid Foundation; GI Cancer Research Gift Fund
Not yet recruiting - verified May 2010 - Condition: Ovarian Neoplasms
Interventions: Drug: Vorinostat; Drug: Vorinostat
Sponsors: Gynecologic Oncology Associates; Gynecologic Oncology Associates; Merck
Recruiting - verified June 2011 - Conditions: Melanoma; Myelodysplastic Syndrome; Multiple Myeloma; Lymphoma
Intervention: Other: Tissue Registry Study
Sponsors: Sarah Cannon Research Institute; Sarah Cannon Research Institute
Recruiting - verified July 2011 - Conditions: Cervical Cancer; Endometrial Cancer; Lymphedema; Vulvar Cancer
Interventions: Other: questionnaire administration; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment; Procedure: study of high risk factors; Procedure: therapeutic conventional surgery; Procedure: therapeutic laparoscopic surgery; Procedure: therapeutic lymphadenectomy
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified August 2009 - Condition: Cancer
Intervention: Other: biologic sample preservation procedure
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified December 2011 - Conditions: Ovarian Cancer; Endometrial Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified November 2011 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cancer; Uterine Cancer; Vaginal Cancer; Vulvar Cancer
Intervention: Behavioral: online platform "STAR" (Symptom Tracking and Reporting for Patients)
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; National Institutes of Health (NIH)
Recruiting - verified January 2012 - Conditions: Cervical Cancer; Endometrial Cancer; Vaginal Cancer
Intervention: Procedure: CT or MRI + Blood Test
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified December 2011 - Conditions: Cervical Cancer; Endometrial Cancer; Vaginal Cancer; Vulvar Cancer; Gynecologic Cancer
Intervention: Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Condition: Gynecologic Diseases
Interventions: Procedure: Laparoscopic supracervical hysterectomy; Procedure: Total laparoscopic hysterectomy
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified May 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab; Drug: carboplatin; Drug: paclitaxel; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Medical Research Council
Recruiting - verified April 2012 - Condition: Endometrial Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified October 2011 - Conditions: Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Pain; Perioperative/Postoperative Complications; Sarcoma
Interventions: Drug: fentanyl citrate; Drug: hydromorphone hydrochloride; Drug: ropivacaine hydrochloride
Sponsors: National Cancer Institute (NCI); University of California, San Francisco; National Cancer Institute (NCI)
Recruiting - verified September 2007
 |
Join Clinical Trials That Study Gynecologic Disorders |
